Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,101 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

NCT07504458

Conditions
Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia, Acute Promyelocytic Leukemia (APL), +12 more
Locations
  • Quetzal Site 1 Duarte, California, United States
  • Quetzal Site 7 Los Angeles, California, United States
  • Quetzal Site 5 Stanford, California, United States
  • Quetzal Site 4 Buffalo, New York, United States
View Trial Details
Recruiting

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

NCT07223814

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • US-San Francisco CA-UCSF San Francisco, California, United States
  • US-Atlanta GA-EMORY Atlanta, Georgia, United States
  • US-Kansas City KS-KUMC Kansas City, Kansas, United States
  • US-Baltimore MD-UMGCCC Baltimore, Maryland, United States
View all 43 locations
View Trial Details
Recruiting

A Study of BGB-11417 in Participants With Myeloid Malignancies

NCT04771130

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Tampa General Hospital Tampa, Florida, United States
  • Upmc Hillman Cancer Center(Univ of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 46 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View Trial Details
Recruiting

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

NCT05442216

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Miami Miami, Florida, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details

Related conditions